Howard Pien Quotes (5 Quotes)

Chiron has recently made tremendous strides, including returning to the U.S. influenza vaccine market, building a compelling oncology pipeline and extending our growth in the blood-testing business,

We ran out of days ... the number of changes we have had to make took us away from being able to produce vaccine.

We believe that our confirmatory testing indicated that the problem was confined to a limited number of lots, ... Therefore, today's action ... is unexpected and disappointing. But we respect the regulatory authority's judgment, because we believe it's fundamentally based on concerns for safety.

We consider 2005 supply something we will update as we have more information in the weeks to come,

he said. ''And we are very hopeful in the weeks that come we can clarify the number much, much more clearly.